GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Additional Paid-In Capital

Peptron (XKRX:087010) Additional Paid-In Capital : ₩15,748 Mil(As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Peptron Additional Paid-In Capital?


Peptron's quarterly additional paid-in capital stayed the same from Sep. 2023 (₩15,748 Mil) to Dec. 2023 (₩15,748 Mil) and stayed the same from Dec. 2023 (₩15,748 Mil) to Mar. 2024 (₩15,748 Mil).

Peptron's annual additional paid-in capital declined from Dec. 2021 (₩132,540 Mil) to Dec. 2022 (₩15,748 Mil) but then stayed the same from Dec. 2022 (₩15,748 Mil) to Dec. 2023 (₩15,748 Mil).

Peptron Additional Paid-In Capital Historical Data

The historical data trend for Peptron's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Peptron Additional Paid-In Capital Chart

Peptron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67,641.61 132,537.99 132,540.00 15,748.00 15,748.00

Peptron Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15,470.14 15,470.14 15,748.00 15,748.00 15,748.00

Peptron Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Peptron Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Peptron's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Peptron (XKRX:087010) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Peptron Inc (XKRX:087010) » Definitions » Additional Paid-In Capital
Comparable Companies
XKRX:950210 XKRX:950160 XKRX:005250 XKRX:310210 XKRX:182400 XKRX:052020 XKRX:215600 XKRX:298380 XKRX:358570 XKRX:005690 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
37-24, Yuseong-daero 1628 beon-gil, Yuseong-gu, Daejeon, KOR, 305811
Website
http://www.peptron.com
Peptron Inc is a biotechnology company engaged in developing fundamental technologies for peptide-based medicines. Its technology includes PeptrEX and SmartDepot. PeptrEX is an automatic system, enabling to synthesize simultaneously from a few to hundred types of peptides. SmartDepot is a proprietary ultrasonic spray drying technology for the preparation of sustained release injectable microsphere formulation of the drug. The group's research and development products include Luphere Depot for the treatment of prostate cancer and endometriosis, SR Exenatide PT302 AND SR EXENATIDE PT304 for the treatment of type II diabetes, SR Exenatide PT320 and 330 for the treatment of Parkinson's and Alzheimer's disease and SR Octreotide for the treatment of acromegaly and carcinoid tumor.

Peptron (XKRX:087010) Headlines

No Headlines